SKO-TRZ Peptide is a synthetic research peptide identified by research catalogs as tirzepatide (TRZ), a dual GIP and GLP-1 receptor agonist. Tirzepatide is a 39-amino-acid peptide studied extensively for its effects on https://tirzepatide-research-pep466895.fitnell.com/84738304/sko-trz-peptide-tirzepatide-research-peptide